Canagliflozin

Details

Files

Generic Name:

Canagliflozin

Project Status:

Withdrawn

Therapeutic Area:

Diabetes Mellitus, Type 2

Manufacturer:

Janssen Inc.

Brand Name:

Invokana

Project Line:

Reimbursement Review

Project Number:

SR0335-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Diabetes mellitus, type 2

Files

Submission Status Report View PDF

Last Updated : June 5, 2013